Orexo develops improved pharmaceuticals based on innovative drug delivery technologies. The focus is primarily on opioid dependence and pain but it is also our aim to address other therapeutic areas where our competence and technologies can create value. The main market today is the American market for buprenorphine/naloxone products, where Orexo commercialize the product Zubsolv®. Other products are commercialized through partners, including sale of Zubsolv outside the US.